Page 181 of 294: studies 1,801 to 1,810 of 2,936, newest first. Back to the psychedelic-assisted therapy overview
The American Journal of Bioethics 2025 Jarrel de Matas, A. L. Mcguire, Hasan Yasin 3 citations
In their contribution to the rapidly developing field of research on psychedelic medicine, Glenn Cohen and Mason Marks shed light on a frequently overlooked but critical aspect of ethical considera...
The American Journal of Bioethics 2025 Zachary J Verne, Natalie Gukasyan, Jeffrey S Zabinski 2 citations
In “Distinctive but not Exceptional: The Risks of Psychedelic Ethical Exceptionalism,” Cheung et al. (2025) elaborate the ways that psychedelics share individual ethical considerations with those o...
PLOS global public health 2025 Ilana Berlowitz, Maria Amalia Pesantes, Cynthia Cárdenas Palacios et al. 6 citations
Peru is among Latin American countries with the largest Indigenous population, yet ethnical health disparities persist, particularly in the Amazon region which comprises 60% of the national territory. Healthcare models that include Indigenous medicine and traditional healers present an important avenue for addressing such inequalities, as they increase cultural adequacy of services, healthcare...
General Hospital Psychiatry 2025 Max Wolff, Hans Rutrecht, Gerhard Gründer et al. 9 citations
Psychedelic treatments are extending beyond research units and into hospitals, outpatient clinics, and community practices. Contrasting the constrained procedures of clinical trials with the realities of routine practice, this article outlines the competencies needed for safe, effective, and ethically sound psychedelic therapy in everyday mental health care. To accommodate mainstream adoption...
Kennedy Institute of Ethics journal 2025 Daniel Villiger
Double-blind, randomized, controlled trials (DB-RCT), if designed and conducted well, are widely considered the gold standard in medical research for purposes of establishing causal efficacy. Their logic is compelling: by balancing out all confounding variables through the research design, DB-RCTs are thought to reveal whether a proposed treatment-by virtue of its characteristic...
Frontiers in Psychiatry 2025 Scott Matthews, Antonino Greco, Clara Rastelli et al. 1 citation
Psychedelic-assisted therapy is a remarkably promising treatment for substance use disorders and for alcohol use disorder (AUD) in particular. Research supporting psychedelics as a safe and effective pharmacotherapy for AUD and its comorbid psychiatric conditions dates from the late1940s and includes over 2,000 published studies. There are, however, challenges to the clinical implementation of...
Bipolar Disorder 2025 Breno Souza-Marques, Ana Teresa Caliman-Fontes, Gustavo C. Leal et al.
Despite the availability of many treatment options, several individuals with bipolar disorders experience persistent symptoms, necessitating the exploration of novel therapeutic approaches. In recent years, there has been a growing interest in repurposing drugs of abuse, such as stimulants, ketamine, and psychedelics, for the treatment of bipolar disorders. While some of these drugs have...
Vibrant Virtual Brazilian Anthropology 2025 Pietro Benedito, Isabel Santana de Rose, Emilia Sanabria et al.
Abstract With the rapid advancement of psychedelic-assisted therapy (PAT) trials, psychedelic clinics are set to become a tangible reality in the near future. Questions abound concerning the therapeutic modalities that will be adopted, the human and material infrastructures that will enable the delivery of this novel form of healthcare, and their funding model - which will have direct...
Progress in Brain Research 2025 Ana Cláudia Mesquita Garcia, Lucas Oliveira Maia
Existential and spiritual suffering are frequently reported by individuals facing serious illnesses, particularly at the end of life, and are associated with diminished quality of life, increased psychological distress, and requests for hastened death. While Palliative Care (PC) aims to provide holistic support, existing therapeutic options often fail to adequately address the profound...
General Hospital Psychiatry 2025 Yvan Beaussant, Elise C. Tarbi, Kabir Nigam et al. 3 citations
Psilocybin-assisted therapy (PAT) shows promise for cancer-related depression, yet little research has examined how therapeutic context shapes patient experiences. While set (mindset) and setting (environment) are considered central to psychedelic treatment, empirical evidence on their role in PAT acceptability remains limited. This study explores factors influencing the acceptability of PAT...